Sept. 1, 2023, 2:57 p.m. |

Latest stories for ZDNET in Artificial-Intelligence www.zdnet.com

Recursion Pharmaceuticals uses machine learning to develop drugs with Bayer and Genentech. CEO Chris Gibson thinks proceeding with that work outweighs any risks a moratorium might prevent.

ai research ceo chris drugs genentech machine machine learning pharma pharmaceuticals recursion recursion pharmaceuticals research risks work

Senior Machine Learning Engineer

@ GPTZero | Toronto, Canada

ML/AI Engineer / NLP Expert - Custom LLM Development (x/f/m)

@ HelloBetter | Remote

Doctoral Researcher (m/f/div) in Automated Processing of Bioimages

@ Leibniz Institute for Natural Product Research and Infection Biology (Leibniz-HKI) | Jena

Seeking Developers and Engineers for AI T-Shirt Generator Project

@ Chevon Hicks | Remote

Senior Applied Data Scientist

@ dunnhumby | London

Principal Data Architect - Azure & Big Data

@ MGM Resorts International | Home Office - US, NV